Filing Details

Accession Number:
0000950103-22-000270
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-01-06 17:07:31
Reporting Period:
2022-01-04
Accepted Time:
2022-01-06 17:07:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1356090 Precigen Inc. PGEN Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1583187 P. Donald Lehr 20374 Seneca Meadows Parkway
Germantown MD 20876
Chief Legal Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-01-04 18,939 $0.00 315,236 No 4 M Direct
Common Stock Disposition 2022-01-05 10,356 $3.59 304,880 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2022-01-04 18,939 $0.00 18,939 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
18,939 No 4 M Direct
Footnotes
  1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.
  2. This sale was effected pursuant to the terms of a 10b5-1 plan adopted by the reporting person and was made in order to pay the tax liability arising from the vesting of RSUs.
  3. The RSUs were granted on January 4, 2019 and the remaining RSUs vest on January 4, 2023.